These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20019466)

  • 1. Editorial: A different approach to cardiovascular risk factors.
    Oğuz A; Kiliç DC; Uzunlulu M
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 6():1-3. PubMed ID: 20019466
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommendations from the Canadian Diabetes Association. 2003 guidelines for prevention and management of diabetes and related cardiovascular risk factors.
    Harris SB; Lank CN
    Can Fam Physician; 2004 Mar; 50():425-33. PubMed ID: 15318682
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing multiple cardiovascular risk factors.
    Blank RC; Brunton S
    J Fam Pract; 2008 Mar; 57(3 Suppl Managing):S13-20. PubMed ID: 18664333
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypertension, diabetes, hypercholesterolemia, and their combinations increased health care utilization and decreased health status.
    Natarajan S; Nietert PJ
    J Clin Epidemiol; 2004 Sep; 57(9):954-61. PubMed ID: 15504638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticipatory care for the diabetic-hypertensive bundle.
    Hart JT
    Prim Care Diabetes; 2008 Dec; 2(4):165-6. PubMed ID: 19008169
    [No Abstract]   [Full Text] [Related]  

  • 6. The diabetic, hypertensive heart: epidemiology and mechanisms of a very high-risk situation.
    Franjic B; Marwick TH
    J Hum Hypertens; 2009 Nov; 23(11):709-17. PubMed ID: 19516273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertension as a part of metabolic cardiovascular syndrome].
    Os I; Hjermann I; Nordby G
    Tidsskr Nor Laegeforen; 1991 Oct; 111(25):3062-4. PubMed ID: 1948918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing cardiovascular risk in patients with type 2 diabetes mellitus.
    Nicholls SJ; Rydén L
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S1. PubMed ID: 20489414
    [No Abstract]   [Full Text] [Related]  

  • 9. Heart protection: controlling risk factors for cardiovascular disease.
    Pennington JC; Tecce MA; Segal BL
    Geriatrics; 1997 Dec; 52(12):40-2,45,49-50; quiz 51. PubMed ID: 9413251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of diabetes in cardiac diseases].
    Işik S; Delibaşi T; Berker D; Aydin Y; Güler S
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):238-47. PubMed ID: 19520659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and hypertension. Patients in double jeopardy for cardiovascular disease.
    McLaughlin T; Reaven G
    Geriatrics; 2000 Jun; 55(6):28-32, 35. PubMed ID: 10872343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple risk factor intervention in type 2 diabetes: an opportunity not to be missed.
    Cockcroft JR; Wilkinson IB; Yki-Järvinen H
    Diabetes Obes Metab; 2001 Feb; 3(1):1-8. PubMed ID: 11213594
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diabetes and hypertension. Results from the ADVANCE study].
    Mehlsen J
    Ugeskr Laeger; 2008 Feb; 170(7):531-2. PubMed ID: 18291082
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular risk prevalence, awareness, treatment, and control from 1998 to 2007 in Koreans.
    Lee K
    Asia Pac J Clin Nutr; 2010; 19(2):261-5. PubMed ID: 20460242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy and clinical trials: diabetes and cardiovascular risk.
    Peter R
    Curr Opin Lipidol; 2008 Feb; 19(1):101-3. PubMed ID: 18196995
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of cardiovascular diseases. 1998 guidelines of the National Cardiovascular Conference (NCC)].
    Becker HJ; Schwandt P; Held K; Bönner G
    Dtsch Med Wochenschr; 1999 Oct; 124(42):1249-52. PubMed ID: 10572535
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combination therapy of cardiovascular risk factors].
    Weisser B; Grüne S; Mengden T; Spühler T; Vetter W
    Schweiz Rundsch Med Prax; 1992 Jan; 81(3):55-9. PubMed ID: 1733004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introductory remarks.
    Velasco M; Bermúdez V; Israili ZH; Hernández-Hernández R
    Am J Ther; 2010; 17(3):236. PubMed ID: 20479578
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control.
    Parikh NI; Hwang SJ; Larson MG; Meigs JB; Levy D; Fox CS
    Arch Intern Med; 2006 Sep; 166(17):1884-91. PubMed ID: 17000946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease in type 2 diabetics: epidemiology, risk factors and therapeutic modalities.
    Khamaisi M; Wexler ID; Skrha J; Strojek K; Raz I; Milicevic Z
    Isr Med Assoc J; 2003 Nov; 5(11):801-6. PubMed ID: 14650106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.